rs367543061
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM5PP5_Very_Strong
The NM_001384732.1(CPLANE1):c.4006C>T(p.Arg1336Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,324 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1336Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001384732.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPLANE1 | NM_001384732.1 | c.4006C>T | p.Arg1336Trp | missense_variant | 23/53 | ENST00000651892.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPLANE1 | ENST00000651892.2 | c.4006C>T | p.Arg1336Trp | missense_variant | 23/53 | NM_001384732.1 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152008Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248782Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134708
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461316Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 726978
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152008Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74216
ClinVar
Submissions by phenotype
Joubert syndrome 17 Pathogenic:3Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 06, 2012 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Department of Rehabilitation Medicine, Incheon St. Maryβs Hospital, College of Medicine, The Catholic University of Korea | - | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 16, 2020 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31981491, 20301500, 26092869, 22425360, 26477546) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jul 03, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 1336 of the CPLANE1 protein (p.Arg1336Trp). This variant is present in population databases (rs367543061, gnomAD 0.004%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 22425360). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 31219). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CPLANE1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Joubert syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | not provided | Institute of Human Genetics, University Hospital of Duesseldorf | - | - - |
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 01, 2022 | Variant summary: CPLANE1 c.4006C>T (p.Arg1336Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.1e-05 in 280178 control chromosomes. c.4006C>T has been reported in the literature as a compound heterozygous genotype in multiple individuals affected with Joubert Syndrome (example, Srour_2012, Bachmann-Gagescu_2015). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories, a research program and the Gene Reviews database have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at